Homebuilders are upgraded at Credit Suisse, and Herbalife is initiated with an 'overweight.'
Based on historic patterns of yield, here are ten undervalued blue chips for growth and income.
Johnson & Johnson's recently approved Zytiga continues to score at the expense of Dendreon's Provenge.
Pre-announcing sales didn't lessen the angst.
This time, the problem isn't with Tylenol but with its delivery method.
After declaring equities safer than bonds and gold, the billionaire sets an example with several purchases.
The company has made significant investments in the region as a whole to insulate itself from the volatility of the individual markets.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The retailer labels the character's fake memoir as non-fiction. This comes weeks after it categorized the the Bible as fiction.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Preteens, rejoice. The grown-ups have a compelling reason to consider getting you a tablet this year. Adults, listen up.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.